Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study
2019 · The Lancet Oncology · 194 citations
https://doi.org/10.1016/s1470-2045(19)30276-1